Pulmonx Corporation

NASDAQ: LUNG · Real-Time Price · USD
1.54
0.03 (1.99%)
At close: Aug 15, 2025, 3:09 PM

Pulmonx Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-56.39M -60.84M -58.92M -48.66M
Depreciation & Amortization
1.49M 1.55M 1.51M 867K
Stock-Based Compensation
22.95M 22.1M 16.45M 10.53M
Other Working Capital
-2.44M -27K -1.43M 957K
Other Non-Cash Items
409K 2.14M 2.85M 2.47M
Deferred Income Tax
n/a n/a 49K 1.26M
Change in Working Capital
n/a -2.56M -7.01M -7.85M
Operating Cash Flow
-31.54M -37.61M -45.08M -41.39M
Capital Expenditures
-1.45M -807K -1.32M -3.67M
Cash Acquisitions
n/a n/a 2.91M 42.58M
Purchase of Investments
-27.91M -46.2M -47.19M -52.58M
Sales Maturities Of Investments
46.84M 45M 44.28M 10M
Other Investing Acitivies
n/a n/a -2.91M -42.58M
Investing Cash Flow
17.48M -2.01M -4.22M -46.26M
Debt Repayment
-95K 19.91M -87K n/a
Common Stock Repurchased
1.24M 1.18M -27K -26K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.46M 1.49M 2.51M 4.46M
Financial Cash Flow
1.36M 21.4M 2.47M 4.46M
Net Cash Flow
-12.62M -18.18M -46.74M -83.08M
Free Cash Flow
-32.98M -38.42M -46.4M -45.06M